Connect Biopharma Holdings Ltd
Develops immune modulators for T cell-driven inflammatory diseases like asthma and COPD.
CNTB | US
Overview
Corporate Details
- ISIN(s):
- US2075231017
- LEI:
- Country:
- United States of America
- Address:
- 3580 CARMEL MOUNTAIN ROAD, SUITE 200, 92130 SAN DIEGO
- Website:
- https://www.connectbiopharm.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Connect Biopharma Holdings Ltd. is a global, clinical-stage biopharmaceutical company dedicated to developing therapies for inflammatory diseases. The company focuses on the discovery and development of next-generation immune modulators designed to treat T cell-driven autoimmune and inflammatory conditions. Its clinical pipeline aims to transform care for patients with chronic diseases, including asthma and Chronic Obstructive Pulmonary Disease (COPD).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Connect Biopharma Holdings Ltd filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Connect Biopharma Holdings Ltd
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Connect Biopharma Holdings Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
